Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney

American Journal of Physiology

Volumn 271, Issue 2 PART 2, 1996, Pages

  Ikenaga, Hideki ^a   Fallet, Rachel W ^a   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Afferent arteriole; Arginine vasopressin; Efferent arteriole; Nitro l arginine; Norepinephrine

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; JUXTAGLOMERULAR APPARATUS; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; ARGININE VASOPRESSIN; ARTERIOLES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0029736658     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.271.2.f365     Document Type: Article

References (33)

1. Alberola, A. M., F. J. Salazar, T. Nakamura, and J. P. Granger. Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs. Am. J. Physiol. 267(Regulatory Integrative Comp. Physiol. 36): R1472-R1478, 1994.
2. Bachmann, S., H. M. Bosse, and P. Mundel. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am. J. Physiol. 268(Renal Fluid Electrolyte Physiol. 37): F885-P898, 1995.
3. Baker, C. H., and E. T. Sutton. Modification of vasopressin microvascular responses by endotoxin, endothelin, and nitric oxide. Circ. Shock 42: 59-67, 1994.
4. Baylis, C., J. Harvey, and K. Engels. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II. J. Am. Soc. Nephrol. 5: 211-214, 1994.
5. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension Dallas 26: 752-757, 1995.
6. Braam, B., and H. A. Koomans. Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness. Kidney Int. 48: 1406-1411, 1995.
7. Carmines, P. K. Segment-specific effect of chloride channel blockade on rat renal arteriolar contractile responses to angiotensin II. Am. J. Hypertens. 8: 90-94, 1995.
8. Casellas, D., and L. C. Moore. Autoregulation and tubuloglomerular feedback in juxtamedullary afferent arterioles. Am. J. Physiol. 258(Renal Fluid Electrolyte Physiol. 27): F660-F669, 1990.
9. Casellas, D., and L. G. Navar. In vitro perfusion of juxtamedullary nephrons in rats. Am. J. Physiol. 246(Renal Fluid Electrolyte Physiol 15): F349-F358, 1984.
10. Chou, S. Y., and J. G. Porush. Renal actions of endothelin-1 and endothelin-3: interactions with the prostaglandin system and nitric oxide. Am. J. Kidney Dis. 26: 116-123, 1995.
11. Churchill, P. C., and V. R. Ellis. Pharmacological characterization of the renovascular P2 purinergic receptors. J. Pharmacol. Exp. Ther. 265: 334-338, 1993.
12. Deng, A., and C. Baylis. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am. J. Physiol. 264(Renal Fluid Electrolyte Physiol. 33): F212-F215, 1993.
13. Edwards, R. M., and W. Trizna. Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors. J. Am. Soc. Nephrol. 4: 1127-1132, 1993.
14. Harrison-Bernard, L. M., and P. K. Carmines. Juxtamedullary microvascular responses to arginine vasopressin in rat kidney. Am. J. Physiol. 267(Renal Fluid Electrolyte Physiol. 36): F249-F256, 1994.
15. Hoffend, J., A. Cavarape, K. Endlich, and M. Steinhausen. Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation. Am. J. Physiol. 265(Renal Fluid Electrolyte Physiol. 34): F285-F292, 1993.
16. ω-Nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol. 176: 219-223, 1990.
17. Ito, S., S. Arima, Y. L. Ren, L. A. Juncos, and O. A. Carretero. Endothelium-derived relaxing factors/nitric oxide modulates angiotensin II action on the isolated perfused rabbit afferent but not efferent arteriole. J. Clin. Invest. 91: 2012-2019, 1993.
18. Juncos, L. A., Y. L. Ren, S. Arima, and S. Ito. Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arterioles of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products. J. Clin. Invest. 9: 1374-1379, 1993.
19. Juncos, L. A., Y. L. Ren, S. J. Arima, J. Garvin, O. A. Carretero, and S. Ito. Angiotensin II action in isolated microperfused rabbit afferent arterioles is modulated by flow. Kidney Int. 49: 374-381, 1996.
20. G-monomethyl-L-arginine and L-arginine on acetylcholine renal response. Hypertension Dallas 15: 659-663, 1991.
21. Lahera, V., M. G. Salom, M. J. Fiksen-Olsen, and J. C. Romero. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am. J. Hypertens. 4: 260-262, 1991.
22. Lombard, J. H., H. Eskinder, K. Kauser, J. L. Osborn, and D. R. Harder. Enhanced norepinephrine sensitivity in renal arteries at elevated transmural pressure. Am. J. Physiol. 259(Heart Circ. Physiol. 28): H29-H33, 1990.
23. G-nitro-L-arginine, a nitric oxide synthase inhibitor. biol. Pharmacol. Bull. 18: 496-500, 1995.
24. Ohishi, K., and P. K. Carmines. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J. Am. Soc. Nephrol. 5:1559-1566, 1995.
25. Ohishi, K., P. K. Carmines, E. W. Inscho, and L. G. Navar. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am. J. Physiol. 263(Renal Fluid Electrolyte Physiol. 32): F900-F906, 1992.
26. Reid, J. J., and M. J. Rand. Renal vasoconstriction is modulated by nitric oxide. Clin. Exp. Pharmacol. Physiol. 19: 376-379, 1992.
27. Rudichenko, V. M., and W. H. Beierwaltes. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J. Vasc. Res. 32:100-105, 1995.
28. Schnackenberg, C. G., F. C. Wilkins, and J. P. Granger. Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs. Hypertension Dallas 26: 1024-1029, 1995.
29. Sigmon, D. H., O. A. Carretero, and W. H. Beierwaltes. Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension Dallas 20: 643-650, 1992.
30. Sun, D., A. Huang, A. Koller, and G. Kaley. Plow-dependent dilation and myogenic constriction interact to establish the resistance of skeletal muscle arterioles. Microcirculation 2: 289-295, 1995.
31. Takayasu, M., Y. Kajita, Y. Suzuki, M. Shibuya, K. Sugita, and H. Hidaka. A role of nitric oxide in vasomotor control of cerebral parenchymal arterioles in rats. J. Auton. Nerv. Syst. 49: S63-S66, 1994.
32. Takenaka, T., K. D. Mitchell, and L. G. Navar. Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat. J. Am. Soc. Nephrol. 4: 1046-1053, 1993.
33. Zatz, R., and G. De Nucci. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am. J. Physiol. 261(Renal Fluid Electrolyte Physiol. 30): F360-F363,1991.